Lonnel Coats

Chief Executive Officer at Lexicon Pharmaceuticals Inc.

Sits on 3 boards. Last updated September 28, 2026

Time on boards

Boards served
3
Current seats
3
Board service
5 years
Director since
2023

5 years of board service in total across 3 boards, counting each seat separately. Longest: Lexicon Pharmaceuticals Inc., 3 years.

Lexicon Pharmaceuticals Inc. Director · Chief Executive Officer
3 years · Since 2023
1 year · Since 2025
4 weeks · Since 2026

Chief executive roles

Lexicon Pharmaceuticals Inc. · Chief Executive Officer
Until July 2024 · Former

Shareholder support

Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Date Company Transaction Shares Price Value
Oct 19, 2026 Mineralys Therapeutics Inc. Grant or award +12,400 — —
Feb 28, 2024 Lexicon Pharmaceuticals Inc. Option exercise +33,333 — —
Feb 28, 2024 Lexicon Pharmaceuticals Inc. Option exercise +91,364 — —
Feb 28, 2024 Lexicon Pharmaceuticals Inc. Option exercise +120,383 — —
Feb 28, 2024 Lexicon Pharmaceuticals Inc. Shares withheld for tax −61,371 $2.62 $160,792
Nov 16, 2023 Lexicon Pharmaceuticals Inc. Open-market purchase +90,000 $1.05 $94,500
Nov 10, 2023 Lexicon Pharmaceuticals Inc. Open-market purchase +10,000 $1.01 $10,100
Jun 29, 2023 Lexicon Pharmaceuticals Inc. Open-market purchase +10,000 $2.16 $21,600
Jun 26, 2023 Lexicon Pharmaceuticals Inc. Open-market purchase +10,000 $2.18 $21,800
Jun 23, 2023 Lexicon Pharmaceuticals Inc. Open-market purchase +10,000 $2.50 $25,000
Jun 22, 2023 Lexicon Pharmaceuticals Inc. Open-market purchase +40,000 $2.31 $92,400
Feb 28, 2023 Lexicon Pharmaceuticals Inc. Option exercise +84,630 — —
Feb 28, 2023 Lexicon Pharmaceuticals Inc. Option exercise +33,334 — —
Feb 28, 2023 Lexicon Pharmaceuticals Inc. Option exercise +91,363 — —
Feb 28, 2023 Lexicon Pharmaceuticals Inc. Shares withheld for tax −50,971 $2.17 $110,607

Questions about Lonnel Coats

What boards is Lonnel Coats on?

Lonnel Coats sits on the boards of Lexicon Pharmaceuticals Inc., Mineralys Therapeutics Inc. and Relay Therapeutics Inc.

Has Lonnel Coats been a CEO?

Yes — Lonnel Coats was CEO of Lexicon Pharmaceuticals Inc. (Until July 2024).

How long has Lonnel Coats served on boards?

Our records show at least 5 years of board service across 3 boards, the earliest from 2023.

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.